Stem Cell Stocks 2/23/09 - 2/27/09 the Week That Was
These stocks continued to struggle last week. Initially, the larger caps were slightly safer as far as protecting against huge losses, but even those are making huge turns south. For the first time since we've followed these stocks, all the large caps are below their share price prior to Geron Corp's pivotal announcement on 1/23/09. The past 2 or 3 weeks where there was only one up day a week has become commonplace. I would not be to eager to go out and buy anything in this sector until there is some sort of reversal in the trend. See below for a summary of last week's stem cell stock moves.
Top Stem Cell Stock Performer(s) of the Week:
- International Stem Cell Corp (ISCO) = Up 11% for the week; Up 52% the last two trading days on higher than normal trading volume; Since there was no news associated with late week move, I wouldn't read too much into the price spike. I definitely would not recommend chasing.
Worst Stem Cell Stock Performer(s) of the Week:
- StemCells, Inc (STEM) = Down -20% for the week; Pretty much representative of the entire stem cell sector. Down 4 out of the 5 trading days. Being dragged down with the rest of the market
Market Cap Over 50 Million
Ariad Pharmaceuticals (ARIA) = Current Price: $1.11; Down -23%
Aastrom Biosciences (ASTM) = Current Price: $0.37; Down -28%
BioTime, Inc. (BTIM) = Current Price: $1.68; Down -20%
Celgene Corp (CELG) = Current Price: $44.73; Down -9%
Cytori Therapeutics (CYTX) = Current Price: $2.76; Down -14%
Geron Corp (GERN) = Current Price: $4.60; Down -12%
ThermoGenesis (KOOL) = Current Price: $0.48; Down -12%
Osiris Therapeutics (OSIR) = Current Price: $17.90; Down -9%
StemCell Inc. (STEM) = Current Price: $1.56; Down -26%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.PK) = Current Price: $0.12; Unchanged
Athersys Inc. (ATHX) = Current Price: $0.60; Down -12%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.09; Down -10%
Bioheart Inc. (BHRT) = Current Price: Current Price: $1.01; Up 28%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0101; Up 166%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.60; Up 30%
Neuralstem (CUR) = Current Price: $0.94; Down -34%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.50; Up 72%
LifeStem International (LSTM.OB) = Current Price: $0.0088; Up 126%
MultiCell Technologies (MCET.OB) = Current Price: $0.0115; Up 167%
Pluristem Therapeutics (PSTI) = Current Price: $1.05; Up 65%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.06; Up 20%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.0075; Up 36%
Possible Catalyst for the Week:
- Again there is the potential for President Obama to give an executive order to allow funding for stem cell research; If this happens during this continual downward trend in the market the pop will be short lived
- Much like last week, the catalyst is a technical bounce in the overall market. The DOW is only about 60pts from 7000. If the market tanks heavy and hard (down 250 - 300 pts) on Monday to about 6800, I would expect a hard intra-day reversal. If you are quick with the trigger, you can make a lot of money.
Subscribe to:
Post Comments (Atom)
Posts
If we are quick with the trigger to get in for that spike with the Obama news, whenever it happens, which ones do you recommend for the largest percentage gain for just a day trade or to hold no more than a few days? Thanks
ReplyDeleteOn the other hand, if you stayed 'holstered', you may have saved some money!
ReplyDeleteM, the best option for a quick gain will always be MCET, because it has one of the lowest floats. However, it may not move until a day or two after any news.
ReplyDeleteRegarding my previous take on the market's movement, it only applies if the intra-day movement down is sharp and quick. These slow and methodical grinds lower, don't respond with quick reversals. The next level to hit is the S&P500's 650 level. I'll discuss in my next blog.